Each week, Weight & Measure highlights studies worth your attention, explains their findings, and puts their limits into plain language.
Metabolic & bariatric surgery was associated with lower cancer risk
A population-based study published October 14 followed 784,105 people with obesity in Denmark, Finland, and Sweden; 99,614 underwent metabolic & bariatric surgery. The surgery group had a 19% lower adjusted rate of obesity-related cancers overall than the nonsurgical group. The association was broadly similar across the studied age groups and sexes.
The analysis also reported a higher rate of pancreatic cancer after surgery, particularly among younger adults. Because this was an observational study, it cannot establish that surgery caused either the lower overall cancer rate or the pancreatic finding.
Worth reading: Original peer-reviewed study ↗ · Related Weight & Measure guide →
Reports of nonapproved retatrutide use raise patient safety questions
Retatrutide remains investigational. In an October 14 research letter, investigators examined public social media discussions by people reporting retatrutide use. Reported symptoms included nausea, fatigue, insomnia and increased heart rate.
Social media reports cannot establish side-effect rates or prove causation. The researchers could not verify the identity, purity or dose of products reportedly used outside trials. These observations are signals for further research, not a comparison of retatrutide safety with approved OMMs.
Worth reading: Original peer-reviewed study ↗ · Related Weight & Measure guide →
Words in medical records and healthcare encounters can affect trust
A survey published October 13 examined experiences with disrespectful or judgmental language among 500 US adults. The participants included 358 patient-portal users, who were asked about language in medical records, and 142 nonportal users, who reported experiences with language during healthcare encounters. Roughly one in six respondents reported encountering disrespectful or judgmental language. Respondents reporting these experiences more often expressed distrust of clinicians’ documentation, and many indicated they would be less willing to return to the clinician.
The survey covered healthcare broadly, not obesity care specifically. It relied on participants’ reports and cannot establish that the language itself caused lower trust. It raises an important question for care teams: Would the person being described feel accurately and respectfully represented?
Worth reading: Original peer-reviewed study ↗ · Related Weight & Measure guide →
What we're watching
The cancer study offers an important long-term observational finding. The retatrutide and medical-record studies raise distinct questions about safety and trust. None of these studies alone should determine an individual treatment decision.
Weight & Measure translates obesity science for the people living it. Educational information only, not personal medical advice.